期刊文献+

随访干预对患者服用华法令自我管理的影响 被引量:2

THE EFFECT OF FOLLOW-UP INTERVENTION ON SELF MANAGEMENT OF PATIENTS TAKING WARFARIN
暂未订购
导出
摘要 目的探讨随访干预对服用华法令患者自我管理的影响。方法将2010年1月~12月在心血管内科住院接受华法令治疗的80例慢性永久性心房颤动患者随机分为对照组和干预组各40例。干预组出院后实施6个月的随访干预,即对患者进行服药、饮食、监测INR值、预防并发症等指导。对照组出院后未予以主动随访。6个月后评价两组抗凝达标天数、服药依从性、饮食依从性、并发症发生率。结果干预组以上各项均显著优于对照组(p<0.05)。结论随访干预可提高患者参与华法令的自我管理。 Objective To explore the effect of follow-up intervention on self-management of patients taking warfarin. Methods From 2010 January to December,80 cases of chronic permanent auricular fibrillation patients admitted in our hospital cardiovascular medicine department for warfarin treatment were randomly divided into the control group and the intervention group with each 40 cases.Intervention group after discharge were followed up for 6 months with intervention on drugs,guiding of diet,monitoring INR,prevent complication guidance,etc.The control group has not been active follow-up after discharge.Six months after discharge compare the days reaching anticoagulation evaluation standards,medication compliance,diet compliance and complication rate of two groups. Results The outcomes of intervention group were all significantly better than those in the control group(p0.05). Conclusion Follow-up intervention can improve patient involvement in warfarin self management.
出处 《现代医院》 2012年第2期143-144,共2页 Modern Hospitals
关键词 永久性心房颤动 华法令 自我管理 随访干预 Permanent auricular fibrillation Warfarin self-management Follow-up intervention
  • 相关文献

参考文献7

二级参考文献8

共引文献393

同被引文献20

  • 1Alexander,JH,Lopes,RD,James S,et al.Apixaban with antiplatelet therapy after acute coronary syndrome [J].N Engl J Med,2011,365(8),699-708.
  • 2Turpie AG,Lassen MR,Davidson BL,et al.Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial [J]. Lancet,2009,373(9676): 1673-1680.
  • 3Kulbertus H,Lancellotti P.Fibrillation,an epidemicin the elderly [J].RevMedLiege,2014,69(5-6):301-308.
  • 4Saraf K,Morris P, Garg P, et al.Non-vitamin K antagonist oral anticoagulants(NOACs):clinical evidence and therapeutic considerations [J].PostgradMedJ,2014,90(1067):520-528.
  • 5Shurlock B.New oral anticoagulants for non- valvular atrial fibrillation:harder to handle than expected [J]. Eur Heart J,2014,35(28): 1825-1836.
  • 6Evers KA. The hidden burden of atrial fibrillation on healtheare spending and resources in Mississippi [ J ]. J Miss State Med Assoc,2011,52(5) :148-151.
  • 7Casciano JP, Dotiwala ZJ, Martin BC, et al. The costs of warfarin underuse and nonadherence in patients with atrial fibrillation-, a commercial insurer perspective [ J]. J Manag Care Pharm,2013, 19(4) :302-316.
  • 8段亚敏.小剂量低强度华法令抗凝治疗非瓣膜性房颤的临床研究[J].亚太传统医药,2010,6(7):58-59. 被引量:1
  • 9涂荣会,钟国强,曾志羽,伍伟锋,何燕.抗血小板与抗凝治疗预防非瓣膜性心房颤动缺血性卒中的疗效评价[J].中华心血管病杂志,2011,39(3):262-267. 被引量:27
  • 10葛支忱,张华.健康教育路径对房颤患者服用华法令依从性的影响[J].心血管病防治知识(学术版),2011,1(3):142-142. 被引量:1

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部